TC Biopharm (Holdings) Plc Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
WOLVERINE ASSET MANAGEMENT LLC | 02/03/2025 | 668.32 K | $6.62 K | 100.00% | 2.22% |
KEPOS CAPITAL LP | 02/11/2025 | 470.59 K | $5.00 K | 0.00% | 1.56% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 235.29 K | $2.33 K | 0.00% | 0.78% |
CSENGE ADVISORY GROUP | 01/30/2025 | 23.86 K | $236 | 26.51% | 0.08% |
UBS GROUP AG | 02/14/2025 | 2.40 K | $24 | 103.22% | 0.01% |
ARMISTICE CAPITAL, LLC | 02/14/2025 | 188 | $2 | 100.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
TC Biopharm (Holdings) Plc institutional Ownership - FAQ's
During the previous two years, 4 institutional investors and hedge funds held shares of TC Biopharm (Holdings) Plc. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 0
Nantahala Capital Management, LLC: 0
UBS Group AG: 0
Empery Asset Management, LP: 2.82 M
4.65% of TC Biopharm (Holdings) Plc stock is owned by institutional investors.
Institutional investors have bought a total of 2.82 M shares in the last 24 months. This purchase volume represents approximately $0 in transactions.